Compare EURX to:
After Hours: 0.00 N/A (N/A) 7:00pm ET
| Last Trade: | 12.09 |
|---|---|
| Trade Time: | Dec 18 |
| Change: | |
| Prev Close: | 12.71 |
| Open: | 12.88 |
| Bid: | 11.45 x 100 |
| Ask: | 12.85 x 100 |
| 1y Target Est: | N/A |
| Day's Range: | 12.01 - 12.90 |
|---|---|
| 52wk Range: | 7.58 - 15.53 |
| Volume: | 51,548 |
| Avg Vol (3m): | 122,057 |
| Market Cap: | 553.18M |
| P/E (ttm): | N/A |
| EPS (ttm): | N/A |
| Div & Yield: | N/A (N/A) |
| Wed, Dec 9 | Coverage initiated on Eurand by Caris & CompanyBriefing.com |
| Mon, Nov 30 | Eurand Launches ZENPEP(TM) (Pancrelipase) Delayed-Release CapsulesMarketwire |
| Fri, Nov 13 | Phase II/III Clinical Study Compares Safety and Efficacy of Two Doses of ZENPEP(TM) (Pancrelipase) Delayed-Release Capsules for Fat Absorption in Adult Chronic Pancreatitis Patients With Exocrine Pancreatic InsufficiencyMarketwire |
| Thu, Nov 5 | Eurand N.V. Q3 2009 Earnings Conference Callat Seeking Alpha |
| Thu, Nov 5 | Q3 2009 EURAND N V Earnings Release - 07:00 am ETCCBN |
| Thu, Nov 5 | Eurand Reports Key Achievements and Strong Revenue Growth for Third Quarter 2009Marketwire |
| Wed, Oct 28 | Eurand to Participate in Upcoming Investor ConferencesMarketwire |
| Wed, Oct 28 | Eurand Completes Public Offering, Including Exercise of the Underwriters' Over-Allotment Option, for Total Net Proceeds of Approximately $103.9 MillionMarketwire |
| Thu, Oct 22 | IPOs Looking Iffyat CNBC |
| Thu, Oct 22 | Eurand Announces Pricing of Offering of Ordinary SharesMarketwire |
Quotes delayed, except where indicated otherwise.
Delay times are 15 mins for NASDAQ, NYSE and Amex.See also delay times for other exchanges.